DIONEX CORP /DE
10-Q, 1997-05-15
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Previous: PRUDENTIAL BACHE WATSON & TAYLOR LTD I, 10-Q, 1997-05-15
Next: ACACIA CAPITAL CORP, 497J, 1997-05-15



                                    This document consists of 14
                                    pages, of which this page
                                    is number 1.



FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
- - -------------------------------

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended March 31, 1997

OR

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934 

	Commission File Number 0-11250 

                  DIONEX CORPORATION				
     (Exact name of registrant as specified in its charter)    

          Delaware                   94-2647429	   
(State or other jurisdiction of    (I.R.S. Employer
 incorporation or organization)   Identification No.)  

1228 Titan Way, Sunnyvale, California  		       94086		   
(Address of principal executive offices)	    (Zip Code)

Registrant's telephone number, including area code (408) 737-0700

                                 NONE						                        
(Former name, former address and former fiscal year, if changed
since last report.)

Indicate by check mark whether the registrant (1) has filed all 
reports required to be filed by Section 13 or 15(d) of the 
Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the registrant was required to 
file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.

                                        YES   X    NO_____

Indicate the number of shares outstanding of each of the issuer's 
classes of common stock, as of May 9, 1997:

         CLASS                    NUMBER OF SHARES

      Common Stock                    11,894,255





<PAGE>
DIONEX CORPORATION
INDEX


PART I.  FINANCIAL INFORMATION


ITEM 1.  FINANCIAL STATEMENTS                                Page

       CONDENSED CONSOLIDATED BALANCE SHEETS
       March 31, 1997 and June 30, 1996..................      3

       CONDENSED CONSOLIDATED STATEMENTS OF INCOME
       Three Months Ended March 31, 1997 and 1996........      4

       CONDENSED CONSOLIDATED STATEMENTS OF INCOME
       Nine Months Ended March 31, 1997 and 1996.........      5

       CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
       Nine Months Ended March 31, 1997 and 1996.........     6-7

       NOTES TO CONDENSED CONSOLIDATED FINANCIAL
       STATEMENTS........................................     8-9


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
         CONDITION AND RESULTS OF OPERATIONS.............    10-13


PART II.  OTHER INFORMATION

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K................      14

SIGNATURES...............................................      14


















2
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
- - -------------

                                               March 31,   June 30,
    ASSETS                                        1997	      1996  	     
                                              (unaudited)
Current assets:
  Cash and equivalents (including invested cash
    of $13,262 at March 31, 1997 and $10,244
    at June 30, 1996)........................  $ 23,590   $ 16,986
  Temporary cash investments.................     6,252     16,551
  Accounts receivable (net of allowance for
    doubtful accounts of $433 at March 31,1997
    and $488 at June 30, 1996)...............    29,570     28,078
  Inventories................................     8,900      8,258
  Deferred tax benefits......................     7,048      6,590
  Prepaid expenses and other.................     1,173      1,336
         Total current assets................    76,533     77,799

Property, plant and equipment, net...........    30,517     30,409
Other assets ................................     6,773      4,978
                                               $113,823   $113,186

  LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Notes payable to banks.....................  $  1,211   $    273
  Accounts payable...........................     5,221      4,381
  Accrued liabilities........................    16,838     18,398
  Income taxes payable.......................     4,208      3,642
  Accrued product warranty...................     3,640      3,217
         Total current liabilities...........    31,118     29,911

Deferred taxes...............................     1,813      1,071
Stockholders' equity:
  Preferred stock (par value $.001 per share;
    1,000,000 shares authorized; none
    outstanding).............................        -          -
  Common stock (par value $.001 per share;
    40,000,000 shares authorized; outstanding:
    11,933,499 shares at March 31, 1997 and   
    12,369,877 shares at June 30, 1996)......    36,051     32,683
  Retained earnings..........................    44,562     49,251
  Accumulated translation adjustments........    (1,103)        34
  Unrealized gain on securities..............     1,382        236  
         Total stockholders' equity..........    80,892     82,204
                                               $113,823   $113,186


See notes to condensed consolidated financial statements. 




3
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
THREE MONTHS ENDED MARCH 31, 1997 AND 1996
(In thousands, except per share amounts)
- - ------------------



                                                      1997     1996	
                                                       (unaudited)

Net sales......................................     $36,646  $34,030
Cost of sales..................................      11,044   10,627

Gross profit...................................      25,602   23,403

Operating expenses:
  Selling, general and administrative..........      11,784   11,317
  Research and product development.............       3,397    2,837

     Total operating expenses..................      15,181   14,154

Operating income...............................      10,421    9,249
 
Other income...................................          -     1,003
Interest income................................         310      502
Interest expense...............................         (18)     (21)

Income before taxes on income..................      10,713   10,733
Taxes on income................................       3,697    3,729

Net income.....................................     $ 7,016  $ 7,004


Net income per common and equivalent share.....     $   .55  $   .51


Common and equivalent shares used in
  computing per share amounts..................      12,644   13,632














 See notes to condensed consolidated financial statements.               


4
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
NINE MONTHS ENDED MARCH 31, 1997 AND 1996
(In thousands, except per share amounts)
- - ------------------


                                                      1997     1996	  
                                                       (unaudited)

Net sales...................................       $104,754  $98,096 
Cost of sales...............................         31,782   30,810 

Gross profit................................         72,972   67,286 

Operating expenses:
  Selling, general and administrative.......         35,549   34,593
  Research and product development..........          9,271    8,508

     Total operating expenses...............         44,820   43,101

Operating income............................         28,152   24,185

Other income................................             -     1,003 
Interest income.............................          1,022    1,615
Interest expense............................            (66)     (67)

Income before taxes on income...............         29,108   26,736
Taxes on income.............................         10,043    9,290

Net income..................................       $ 19,065  $17,446


Net income per common and equivalent share..       $   1.49  $  1.26


Common and equivalent shares used in
  computing per share amounts...............         12,754   13,876














 See notes to condensed consolidated financial statements.               


5
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NINE MONTHS ENDED MARCH 31, 1997 AND 1996
(In thousands)
- - ------------------

                                                     1997      1996	 
                                                       (unaudited)
Cash and equivalents provided by (used for):

Cash flows from operating activities:
Net income......................................   $19,065   $17,446
Adjustments to reconcile net income to net cash
  provided by operating activities:
  Depreciation and amortization.................     1,886     2,222
  Deferred taxes................................      (517)   (1,673)
  Gain on sale of property......................        -     (1,003) 

  Changes in assets and liabilities:
    Accounts receivable.........................    (3,278)   (2,619)
    Inventories.................................    (1,126)     (298)
    Prepaid expenses and other assets...........        98       373 
    Accounts payable............................       963     1,101 
    Accrued liabilities.........................    (1,298)    1,457 
    Income taxes payable........................       720      (314)
    Accrued product warranty....................       478       313
Net cash provided by operating activities.......    16,991    17,005

Cash flows from investing activities:
  Purchase of temporary cash investments........   (14,600)  (27,549)
  Proceeds from maturities of temporary
    cash investments............................    24,899    25,582
  Purchase of property, plant and equipment.....    (2,150)   (1,661)
  Proceeds from sale of property................        -      3,812 
  Other.........................................      (124)       47 
Net cash provided by investing activities.......     8,025       231 

Cash flows from financing activities:
  Net change in notes payable to banks..........     1,044        (5)
  Sale of common stock..........................     5,212     2,926
  Repurchase of common stock....................   (25,599)  (29,635)
  Other.........................................        21      (407) 
Net cash used for financing activities..........   (19,322)  (27,121)

Effect of exchange rate changes on cash.........       910     1,962 

Net increase(decrease)in cash and equivalents...     6,604    (7,923)
Cash and equivalents, beginning of period.......    16,986    36,165

Cash and equivalents, end of period.............   $23,590   $28,242
(continued)




6
<PAGE>


DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NINE MONTHS ENDED MARCH 31, 1997 AND 1996
(In thousands)
- - ------------------
                                                  1997     1996
                                                   (unaudited)
(continued)
Supplemental disclosures of cash flow information:
  Income taxes paid.............................$8,199   $10,824
  Interest paid.................................$   64   $    66








See notes to condensed consolidated financial statements.                







7
<PAGE>
DIONEX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(Unaudited)
- - ------------------



1.  Basis of Presentation

The condensed consolidated financial statements included
herein have been prepared by the Company, without audit,
pursuant to the rules and regulations of the Securities and
Exchange Commission.  Certain information and footnote
disclosures normally included in financial statements
prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such
rules and regulations, although the Company believes the
disclosures which are made are adequate to make the
information presented not misleading.  It is suggested that
these condensed consolidated financial statements be read
in conjunction with the consolidated financial statements
and the notes thereto included in the Company's Annual
Report to Stockholders for the fiscal year ended
June 30, 1996. 

The unaudited condensed consolidated financial statements
included herein reflect all adjustments (which include only
normal, recurring adjustments) which are, in the opinion of
management, necessary to state fairly the results for the
periods presented.  The results for such periods are not
necessarily indicative of the results to be expected for
the entire fiscal year ending June 30, 1997.

2.  Inventories

    Inventories consist of (in thousands):
				     								
                                    March 31,	  June 30,
                                      1997        1996	  

    Finished goods                  $3,830       $3,160
    Work in process                  2,577        1,847
    Raw materials and subassemblies  2,493        3,251

                                    $8,900       $8,258

3.   Income Taxes

The effective income tax rate for the first nine months of
fiscal 1997 was 34.5%, down slightly from the 34.8% reported
in the same period of fiscal 1996.





8
<PAGE>
DIONEX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(Unaudited)
- - ------------------


4.   Net Income Per Share
 
Net income per common and equivalent share is computed by
dividing net income by the weighted average number of common
shares and dilutive common share equivalents outstanding
during each period.  The difference between primary and
fully diluted net income per share is not significant in any
period.  

5.   Common Stock Repurchases

During the first nine months of fiscal 1997, the Company
repurchased 679,450 shares of its common stock on the open
market compared with 1,050,900 shares repurchased in the
first nine months of the previous fiscal year.  During all
of fiscal 1996, the Company repurchased 1,601,000 shares.

6.   Recently Issued Accounting Standard

In February 1997, the Financial Accounting Standards Board
issued Statement of Financial Accounting Standards No. 128,
Earnings Per Share (SFAS 128).  The Company is required to
adopt SFAS 128 in the second quarter of fiscal 1998 and
will restate at that time earnings per share (EPS) data for
prior periods to conform with SFAS 128.  Earlier application
is not permitted.  

SFAS 128 replaces current EPS reporting requirements and
requires a dual presentation of basic and diluted EPS. 
Basic EPS excludes dilution and is computed by dividing net
income by the weighted average of common shares outstanding
for the period.  Diluted EPS reflects the potential dilution
that could occur if securities or other contracts to issue
common stock were exercised or converted into common stock.  

If SFAS 128 had been in effect during the current and prior
year periods, basic EPS would have been $.59 and $.54 for
the quarters ended March 31, 1997 and 1996, respectively,
and $1.58 and $1.31 for the nine months ended March 31, 1997 
and 1996, respectively.  Diluted EPS under SFAS 128 would 
not have been significantly different than primary EPS
currently reported for the periods. 









9
<PAGE>
DIONEX CORPORATION


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
	    CONDITION AND RESULTS OF OPERATIONS

Results of Operations - Three Months Ended March 31, 1997
and 1996

Net sales for the third quarter of fiscal 1997 were $36.6 
million, an increase of 8% from the $34.0 million reported for 
the same period last year.  The increase in sales reflects solid 
growth in Japan and North America. Growth in Europe was mixed 
across geographies.  Had currency rates been the same as in last 
year's third quarter, sales growth would have been 13%.

Gross margin for the third quarter of fiscal 1997 was 69.9%, up 
1.1% from the 68.8% reported for the same period last year.  The 
increase in gross margin was due primarily to a more favorable 
product mix, partially offset by an unfavorable effect of 
currency fluctuations.  There were no significant selling price 
changes between these periods.

Operating expenses of $15.2 million for the third quarter of 
fiscal 1997 were up $1.0 million, or 7%, from the $14.2 million 
reported in the same quarter last year.  As a percentage of 
sales, operating expenses were unchanged from the third quarter 
last year.  Selling, general and administrative (SG&A) expenses 
increased $467,000, or 4%, to $11.8 million in the third quarter 
of fiscal 1997.  The increase was due to higher personnel and 
related costs and higher selling costs, partially offset by the 
effect of currency fluctuations on international selling 
expenses. SG&A expenses also increased slightly in the third 
quarter due to the addition of a new subsidiary in Austria, which 
was established effective January 1, 1997.

Research and development (R&D) costs of $3.4 million were up 20% 
from the $2.8 million reported in the same period last year.  The 
increase in costs was due to higher personnel and related costs 
and higher project material costs.  The level of R&D spending 
varies depending on both the breadth of the Company's R&D efforts 
and the stage of specific product development.  

Interest income for the third quarter of fiscal 1997 declined to 
$310,000 from the $502,000 reported in the third quarter last 
year.  The decline was due to a lower average cash balance.  The 
lower average cash balance resulted from the Company's share 
repurchase programs.







10 
<PAGE>
The effective tax rate for the third quarter of fiscal 1997 was 
34.5%, compared with 34.8% in the third quarter a year ago.  
Variations in the tax rate reflect changes in the mix of taxable 
income among the various tax jurisdictions in which the Company 
does business.  The effective tax rate for the remainder of 
fiscal 1997 is expected to be consistent with the first nine 
months of fiscal 1997.  

Net income in the third quarter of fiscal 1997 was $7.0 million, 
unchanged from the $7.0 million reported for the same period last 
year.  Net income in the third quarter of fiscal 1996 included an 
after tax gain of $654,000 from the sale of property. Net income 
per share rose $.04, or 8%, to $.55 compared with $.51 for the 
same period last year. Excluding the gain on sale of property 
which added $.05 per share in the third quarter of fiscal 1996, 
earnings per share would have increased 20%.  Net income per 
share was favorably impacted by the Company's stock repurchase 
programs.

Results of operations - Nine Months Ended March 31, 1997
and 1996

Net sales for the nine months ended March 31, 1997 were $104.8 
million, an increase of 7% over the $98.1 million reported for 
the first nine months of fiscal 1996.  The increase in sales was 
attributable to improved demand in North America and continued  
solid growth in the Company's international markets.  Currency 
fluctuations had an unfavorable effect on sales growth in the 
first nine months of fiscal 1997.  Had currency rates been the 
same as in the first nine months of last year, sales growth would 
have been 11%.  

Gross margin in the first nine months of fiscal 1997 was 69.7%, 
an increase over the gross margin of 68.6% in the first nine 
months of fiscal 1996.  The improvement in gross margin is 
attributable to a favorable mix of products and services sold and 
lower manufacturing costs, partially offset by an unfavorable 
effect of currency fluctuations.  There were no significant 
selling price changes between these periods.

Operating expenses for the first nine months of fiscal 1997 of 
$44.8 million increased 4% from the $43.1 million reported for 
the first nine months last year.  Operating expenses as a 
percentage of sales decreased to 43% from the 44% of sales 
reported last year.  SG&A expenses for the first nine months of 
fiscal 1997 increased 3% to $35.5 million.  Increases in 
personnel and related costs, advertising and selling costs were 
partially offset by the effect of currency fluctuations on 
international selling expenses.  SG&A expenses were 34% of sales 
for the first nine months of fiscal 1997 compared with 35% for 
the same period last year.  






11
<PAGE>
R&D expenses for the first nine months were $9.3 million, an 
increase of $763,000, or 9%, from the $8.5 million reported for
the same period last year.  Personnel and related costs and
project material costs were the primary reasons for the increase
in R&D expenses.  The level of R&D spending varies depending on
both the breadth of the Company's R&D efforts and the stage of
specific product development.

Interest income for the first nine months of fiscal 1997 declined
37% to $1.0 million from $1.6 million reported for the same
period last year.  The decline in interest income was due to a
lower average cash balance.  The lower average cash balance was
caused by share repurchases under the Company's share repurchase
programs.	

The effective income tax rate was 34.5% in the first three
quarters of fiscal 1997, compared to 34.8% in the prior year's
first three quarters.  Variations in the tax rate reflect
variations in the mix of taxable income among the various tax 
jurisdictions in which the Company does business.  The effective 
tax rate for the remainder of fiscal 1997 is expected to be 
consistent with the rate for the first nine months.  

Net income of $19.1 million increased $1.6 million or 9%, from 
the first three quarters of fiscal 1996.  Net income per share 
grew $.23, or 18%, to $1.49 compared with $1.26 for the same 
period last year.  Excluding the gain on the sale of property, 
earnings per share would have increased 23%.  Net income per 
share was favorably impacted by the Company's stock repurchase 
programs.

Liquidity and Capital Resources

The Company's liquidity and capital resources remained strong 
during the first nine months of fiscal 1997.  At March 31, 1997, 
the Company had cash and cash investments of $29.8 million.

During the third quarter of fiscal 1997, the Company repurchased 
122,650 shares of its common stock bringing the total repurchases 
for fiscal 1997 to 679,450 shares compared with 1,050,900 shares 
repurchased in the first nine months of last year.  During all of 
fiscal 1996, the Company repurchased 1,601,000 shares.

At March 31, 1997, the Company's Japanese subsidiary had utilized 
approximately $1.2 million of the Company's $14.5 million in 
committed bank lines of credit.  The Company believes that its 
cash flow from operations, current cash and cash investments and 
the remainder of its $14.5 million bank lines of credit will be 
adequate to meet its cash requirements for the remainder of  
fiscal 1997 and the foreseeable future.  

The impact of inflation on Dionex Corporation's financial 
position and results of operations was not significant during the 
nine months ended March 31, 1997.  


12
<PAGE>
Except for historical information contained herein, the above 
discussion contains forward-looking statements that involve risks 
and uncertainties that could cause actual results to differ 
materially from those discussed here.  Such risks and 
uncertainties include: competition from other products,foreign 
currency fluctuations,general economic conditions,existing 
product obsolescence, fluctuation in worldwide demand for 
analytical instrumentation,new product development, including 
market receptiveness, the ability to manufacture products on an 
efficient and timely basis and at a reasonable cost and in 
sufficient volume, the ability to attract and retain talented 
employees and other risks as described in more detail in the 
Company's Form 10-K.





13
<PAGE>

PART II.  OTHER INFORMATION


Item 6.  Exhibits and Reports on Form 8-K 

(a)  There are no exhibits required to be filed pursuant to
     this Report on Form 10-Q.  

(b)  The Company did not file any reports on Form 8-K during
     the quarter ended March 31, 1997.


SIGNATURES 



PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, 
THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF 
BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.


                              DIONEX CORPORATION
                                 (Registrant)


Date: May 9, 1997   	   By:/s/ A. Blaine Bowman		                 
                           A. Blaine Bowman
                           President, Chief Executive
                           Officer



                        By:/s/ Michael W. Pope
                           Michael W. Pope
                           Vice President, Finance and
                           and Administration
                           (Principal Financial and
                           Accounting Officer)

















14


<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN THE
FORM 10-Q OF DIONEX CORPORAATION FOR THE QUARTER ENDED MARCH 31, 1997
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                           23590
<SECURITIES>                                      6252
<RECEIVABLES>                                    30003
<ALLOWANCES>                                       433
<INVENTORY>                                       8900
<CURRENT-ASSETS>                                 76533
<PP&E>                                           45849
<DEPRECIATION>                                   15332
<TOTAL-ASSETS>                                  113823
<CURRENT-LIABILITIES>                            31118
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         36051
<OTHER-SE>                                       44841
<TOTAL-LIABILITY-AND-EQUITY>                    113823
<SALES>                                         104754
<TOTAL-REVENUES>                                104754
<CGS>                                            31782
<TOTAL-COSTS>                                    31782
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  66
<INCOME-PRETAX>                                  29108
<INCOME-TAX>                                     10043
<INCOME-CONTINUING>                              19065
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     19065
<EPS-PRIMARY>                                     1.49
<EPS-DILUTED>                                     1.49
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission